Rita Prieto

1.1k total citations
34 papers, 749 citations indexed

About

Rita Prieto is a scholar working on Experimental and Cognitive Psychology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Rita Prieto has authored 34 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Experimental and Cognitive Psychology, 14 papers in Pharmacology and 10 papers in Psychiatry and Mental health. Recurrent topics in Rita Prieto's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (17 papers), Treatment of Major Depression (13 papers) and Mental Health Treatment and Access (8 papers). Rita Prieto is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (17 papers), Treatment of Major Depression (13 papers) and Mental Health Treatment and Access (8 papers). Rita Prieto collaborates with scholars based in Spain, United States and United Kingdom. Rita Prieto's co-authors include Stefania Maggi, Jean‐Pierre Michel, Georgia Sykara, Alessandro Monaco, Graziano Onder, Katie Palmer, Miia Kivipelto, Shaantanu Donde, J.A. Micó and Pilar A. Sáiz and has published in prestigious journals such as International Journal of Environmental Research and Public Health, The Journal of Clinical Psychiatry and Osteoarthritis and Cartilage.

In The Last Decade

Rita Prieto

33 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rita Prieto Spain 13 279 145 124 124 96 34 749
Sepideh Behnezhad Iran 18 265 0.9× 105 0.7× 91 0.7× 109 0.9× 47 0.5× 25 771
Richard Berman United States 10 118 0.4× 116 0.8× 118 1.0× 61 0.5× 112 1.2× 31 749
Mitsuhiro Sado Japan 16 275 1.0× 242 1.7× 90 0.7× 187 1.5× 113 1.2× 51 822
Nico Hutter Germany 12 102 0.4× 63 0.4× 111 0.9× 152 1.2× 49 0.5× 13 909
Jill E. Lavigne United States 15 292 1.0× 84 0.6× 45 0.4× 63 0.5× 52 0.5× 50 710
Michael Dworkind Canada 7 187 0.7× 87 0.6× 130 1.0× 296 2.4× 45 0.5× 10 699
Birgit Watzke Germany 17 350 1.3× 159 1.1× 57 0.5× 161 1.3× 69 0.7× 73 844
Philipp Frank United Kingdom 13 222 0.8× 66 0.5× 57 0.5× 67 0.5× 27 0.3× 33 903
Philip R. Muskin United States 17 386 1.4× 105 0.7× 69 0.6× 188 1.5× 26 0.3× 57 940
Miryam Yusufov United States 13 159 0.6× 52 0.4× 60 0.5× 38 0.3× 49 0.5× 39 586

Countries citing papers authored by Rita Prieto

Since Specialization
Citations

This map shows the geographic impact of Rita Prieto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Prieto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Prieto more than expected).

Fields of papers citing papers by Rita Prieto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Prieto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Prieto. The network helps show where Rita Prieto may publish in the future.

Co-authorship network of co-authors of Rita Prieto

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Prieto. A scholar is included among the top collaborators of Rita Prieto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Prieto. Rita Prieto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Masaki, Yuko Asami, Dalia Wajsbrot, et al.. (2020). Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy: Individual patient data analysis. Journal of Psychiatric Research. 129. 160–167. 6 indexed citations
2.
Palmer, Katie, Alessandro Monaco, Miia Kivipelto, et al.. (2020). The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing. Aging Clinical and Experimental Research. 32(7). 1189–1194. 250 indexed citations
3.
McIntyre, Roger S., Rita Prieto, Yu‐Chen Yeh, et al.. (2019). Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study. Current Medical Research and Opinion. 35(12). 2169–2177. 9 indexed citations
4.
Prieto, Rita, et al.. (2019). Efficacy of venlafaxine extended release in major depressive disorder patients. International Clinical Psychopharmacology. 34(3). 110–118. 17 indexed citations
5.
Serpell, Michael, et al.. (2017). Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials. Journal of Pain Research. Volume 10. 1769–1776. 23 indexed citations
6.
Katzman, Martin A., Andrew A. Nierenberg, Dalia Wajsbrot, et al.. (2017). Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 37(5). 555–561. 5 indexed citations
7.
Zhang, Min, et al.. (2017). Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at Baseline. Journal of Clinical Psychopharmacology. 37(2). 182–192. 7 indexed citations
8.
Prieto, Rita, et al.. (2016). Anxiety and depression in knee osteoarthritic patients: Results from EMARTRO study. Osteoarthritis and Cartilage. 24. S218–S219. 4 indexed citations
9.
Prieto, Rita, et al.. (2016). EMARTRO: Study to assess comorbidities in patients with symptomatic knee osteoarthritis. Osteoarthritis and Cartilage. 24. S194–S195. 2 indexed citations
10.
Carrasco, Josep L., Susan G. Kornstein, Roger S. McIntyre, et al.. (2016). An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder. International Clinical Psychopharmacology. 31(3). 134–146. 12 indexed citations
11.
Kasper, Siegfried, et al.. (2013). How well do randomized controlled trial data generalize to ‘real-world’ clinical practice settings? A comparison of two generalized anxiety disorder studies. European Neuropsychopharmacology. 24(1). 125–132. 7 indexed citations
12.
Kasper, Siegfried, Celso Iglesias García, Edward E. Schweizer, et al.. (2013). Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder. The International Journal of Neuropsychopharmacology. 17(5). 685–695. 25 indexed citations
13.
Montgomery, Stuart, et al.. (2013). Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability. Current Medical Research and Opinion. 29(10). 1223–1230. 23 indexed citations
14.
Micó, J.A. & Rita Prieto. (2012). Elucidating the Mechanism of Action of Pregabalin. CNS Drugs. 26(8). 637–648. 48 indexed citations
15.
Roca, Miquel, et al.. (2007). [Gender differences in clinical profile, response and remission of depressive patients treated with venlafaxine extended release].. PubMed. 36(2). 82–9. 2 indexed citations
16.
Ibor, J J López, et al.. (2007). Effectiveness and safety of venlafaxine extended release in elderly depressed patients. Archives of Gerontology and Geriatrics. 46(3). 317–326. 14 indexed citations
17.
Baca, Enrique, et al.. (2006). Venlafaxine extended-release in patients older than 80 years with depressive syndrome. International Journal of Geriatric Psychiatry. 21(4). 337–343. 9 indexed citations
18.
Bobes, Julio, et al.. (2006). Psychometric properties of the Spanish version of the screening scale for DSM-IV Generalized Anxiety Disorder of Carroll and Davidson.. PubMed. 34(2). 83–93. 9 indexed citations
19.
Bernardo, Miquel, et al.. (2003). [Venlafaxine titration dosage in depressive in-patients. A series of cases].. PubMed. 31(1). 31–4. 1 indexed citations
20.
Baca‐García, Enrique, Carmen Díaz-Sastre, Rita Prieto, et al.. (2001). A Prospective Study of the Paradoxical Relationship Between Impulsivity and Lethality of Suicide Attempts. The Journal of Clinical Psychiatry. 62(7). 560–564. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sepideh Behnezhad Breakdown of academic impact, for papers by Richard Berman Breakdown of academic impact, for papers by Mitsuhiro Sado Breakdown of academic impact, for papers by Nico Hutter Breakdown of academic impact, for papers by Jill E. Lavigne Breakdown of academic impact, for papers by Michael Dworkind Breakdown of academic impact, for papers by Birgit Watzke Breakdown of academic impact, for papers by Philipp Frank Breakdown of academic impact, for papers by Philip R. Muskin Breakdown of academic impact, for papers by Miryam Yusufov
Rankless by CCL
2026